This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Shinkei Therapeutics LLC. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Mind of Krunal Raval in Traumatic Brain Injury Treatment
Introduction
Krunal Raval, an accomplished inventor based in Ahmedabad, India, has made significant strides in the field of medical treatment for traumatic brain injuries. With his keen insight and innovative approach, he has developed a unique dosing regimen that harnesses the therapeutic potential of amantadine hydrochloride.
Latest Patents
Raval holds a patent for his invention titled "Amantadine Hydrochloride for the Treatment of Traumatic Brain Injury." This groundbreaking patent outlines a specific dosing regimen for administering an aqueous composition of amantadine hydrochloride to patients suffering from traumatic brain injuries. The regimen consists of two intravenous doses of amantadine hydrochloride, each comprising between 100-200 mg mixed in an aqueous solution of 200-300 ml, delivered over a period of two to four hours. The second dose is strategically administered four to six hours after the first dose has been fully given, optimizing patient recovery.
Career Highlights
Krunal Raval is currently affiliated with Shinkei Therapeutics LLC, where he continues to push the boundaries of medical science. His innovative spirit and dedication to providing better treatment options for individuals with traumatic brain injuries have distinguished him in the field. Raval’s work exemplifies a blend of scientific rigor and compassionate care, paving the way for advancements in therapeutic interventions.
Collaborations
In his professional journey, Raval works closely with Suresh Borsadia, a fellow innovator and collaborator at Shinkei Therapeutics LLC. Their partnership has been instrumental in driving research forward and enhancing the treatment protocols for traumatic brain injury.
Conclusion
Krunal Raval's contributions to the field of medicine through his patent on amantadine hydrochloride represent a significant advancement in the treatment of traumatic brain injuries. His collaboration with like-minded professionals such as Suresh Borsadia ensures that innovative solutions continue to emerge, ultimately benefiting patients and the medical community as a whole. Through his work, Raval exemplifies the spirit of innovation that drives progress in healthcare.